30.40
                                            Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten
Ideaya Biosciences Reports Q3 Net Income, Revenue - MarketScreener
IDEAYA Biosciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
IDEAYA Biosciences posts Q3 profit on Servier deal revenue By Investing.com - Investing.com Nigeria
IDEAYA Biosciences posts Q3 profit on Servier deal revenue - Investing.com
IDEAYA Biosciences Q3 net income beats estimates - MarketScreener
IDEAYA Biosciences Delivers Earnings Surprise And Raises Guidance - Finimize
IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire
IDEAYA Biosciences Inc. stock trend forecastTrade Volume Report & Weekly Return Optimization Alerts - newser.com
How IDEAYA Biosciences Inc. stock reacts to Fed rate cutsJuly 2025 Reactions & High Accuracy Investment Signals - newser.com
Will IDEAYA Biosciences Inc. (30J) stock hit analyst forecastsWeekly Investment Report & Growth Focused Stock Reports - newser.com
Can IDEAYA Biosciences Inc. (30J) stock attract ESG investmentsEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Why IDEAYA Biosciences Inc. stock appeals to analystsJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Using AI based signals to follow IDEAYA Biosciences Inc.Weekly Loss Report & Reliable Entry Point Trade Alerts - newser.com
Is IDEAYA Biosciences Inc. stock a top momentum play2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
Order flow analysis tools used on IDEAYA Biosciences Inc.July 2025 Institutional & Verified Trade Idea Suggestions - newser.com
How to integrate IDEAYA Biosciences Inc. into portfolio analysis tools2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
Why IDEAYA Biosciences Inc. (30J) stock benefits from AI revolutionJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
Published on: 2025-11-03 05:02:09 - newser.com
News impact scoring models applied to IDEAYA Biosciences Inc.2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Will IDEAYA Biosciences Inc. (30J) stock extend growth story2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com
What MACD signals say about IDEAYA Biosciences Inc.2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Will IDEAYA Biosciences Inc. stock see PE expansion2025 Key Lessons & Weekly Top Gainers Trade List - newser.com
Is IDEAYA Biosciences Inc. stock entering bullish territoryEntry Point & Advanced Technical Signal Analysis - newser.com
Institutional scanner results for IDEAYA Biosciences Inc.Weekly Volume Report & Real-Time Volume Analysis Alerts - newser.com
Can IDEAYA Biosciences Inc. stock sustain revenue growthTrade Performance Summary & Long-Term Capital Growth Ideas - newser.com
Will IDEAYA Biosciences Inc. (30J) stock beat revenue estimates2025 Dividend Review & Community Supported Trade Ideas - newser.com
IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events - Sahm
Is IDEAYA Biosciences Inc. stock in correction or buying zoneWeekly Risk Report & Consistent Profit Alerts - newser.com
AlphaQuest LLC Sells 16,763 Shares of IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Will IDEAYA Biosciences Inc. stock remain a Wall Street favoriteMarket Volume Report & Weekly High Momentum Picks - newser.com
IDEAYA Biosciences (NASDAQ:IDYA) Upgraded at Wall Street Zen - MarketBeat
Using flow based indicators on IDEAYA Biosciences Inc.July 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
IDEAYA Biosciences (NASDAQ: IDYA) awards 73,500 inducement options with 4-year vesting - Stock Titan
Visualizing IDEAYA Biosciences Inc. stock with heatmapsJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Clinical Trial Success Propels Ideaya Biosciences Shares to New Heights - AD HOC NEWS
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):